Coronavirus Outbreak: SEBI extends regulatory approval validity for IPO, rights issue by six months

SEBI on Tuesday extended the validity of regulatory approval for launching initial public offering and rights issue by six months in the wake of coronavirus pandemic

Press Trust of India April 21, 2020 19:14:42 IST
Coronavirus Outbreak: SEBI extends regulatory approval validity for IPO, rights issue by six months

New Delhi: SEBI on Tuesday extended the validity of regulatory approval for launching initial public offering and rights issue by six months in the wake of coronavirus pandemic.

The step comes following representations from various industry bodies, the Securities and Exchange Board of India (SEBI) said in a circular.

The validity of SEBI's observations, where the same have expired or will expire between 1 March, 2020 and 30 September, 2020, has been extended by 6 months from the date of expiry of such observation.

 <span class=Coronavirus Outbreak SEBI extends regulatory approval validity for IPO rights issue by six months" width="380" height="285" class="size-full wp-image-4254843" />

Representational image. Reuters.

This is subject to an undertaking from lead manager of the issue confirming compliance with the ICDR (Issue of Capital and Disclosure Requirements) Regulations while submitting the updated offer document to SEBI, it said.

As per the norms, a public issue/rights issue needs to be opened within 12 months from the date of issuance of observations by SEBI.

SEBI's observation is necessary for any company to launch public issues.

The regulator said that an issuer, whose offer document for IPO, follow on public offer and rights issue is pending receipt of its observation, will be permitted to increase or decrease the fresh issue size by up to 50 percent of the estimated issue size without requiring to file a fresh draft offer document with the SEBI.

The relaxation is subject to no change in the objects of the issue, and the lead manager will need to ensure that all appropriate changes are made to the relevant section of DRHP, and an addendum in this regard shall be made public.

The relaxation on change in fresh issue size will be applicable for offer documents pending receipt of SEBI observations until 31 December, 2020.

Under the norms, any increase or decrease in estimated fresh issue size by more than 20 percent of the estimated fresh issue size requires the fresh filing of the draft offer document along with fees.

SEBI said it has decided to grant these one-time relaxations in view of the impact of COVID-19 pandemic.

The circular will come into force with immediate effect, it added.

Updated Date:

also read

Beijing Winter Olympics: IOC urges teams to ask for more vaccines ahead of next year's Games
Sports

Beijing Winter Olympics: IOC urges teams to ask for more vaccines ahead of next year's Games

Health officials in China said this week that more than one billion people, or 72 percent of the country's 1.4 billion citizens, have been fully vaccinated.

Maharashtra logs 3,783 COVID-19 cases, 56 more deaths; toll at 1,38,277
India

Maharashtra logs 3,783 COVID-19 cases, 56 more deaths; toll at 1,38,277

Among the eight regions of Maharashtra, the Pune region reported the highest 1,483 new COVID-19 cases, followed by 970 cases in the Mumbai region

Maharashtra logs 3,595 COVID-19 cases, 45 deaths; toll at 1,38,322
India

Maharashtra logs 3,595 COVID-19 cases, 45 deaths; toll at 1,38,322

Maharashtra's COVID-19 recovery rate stands at 97.06 percent, while the fatality rate is 2.12 percent